Related Experiment Video

Updated: Jul 14, 2026

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
15:05

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons

Published on: February 5, 2015

Acute and sub-chronic functional neurotoxicity of methylphenidate on neural networks in vitro

K V Gopal1, B R Miller, G W Gross

  • 1Department of Speech and Hearing Sciences, University of North Texas, Denton, TX 76203-5010, USA. gopal@unt.edu

Journal of Neural Transmission (Vienna, Austria : 1996)
|June 20, 2007
PubMed

Insights

Methylphenidate (MPH) causes concentration-dependent neurotoxicity in brain networks. While acute exposure inhibits neuronal activity, prolonged exposure can block it, with some recovery observed, impacting attention deficit hyperactivity disorder treatments.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Methylphenidate (MPH) is a primary treatment for attention deficit hyperactivity disorders.
  • The functional toxicity and reversibility of MPH's electrophysiological effects remain unquantified.

Purpose of the Study:

  • To investigate the acute and sub-chronic functional neurotoxicity of MPH on neuronal networks.
  • To quantify concentration-dependent electrophysiological alterations and reversibility.

Main Methods:

  • Utilized spontaneously active neuronal networks on microelectrode arrays (MEAs).
  • Assessed electrophysiologic effects on auditory cortex networks (ACNs) and frontal cortex networks (FCNs).
  • Examined MPH effects at clinical and overdose concentrations, including tyrosine hydroxylase immunocytochemistry.

Main Results:

  • Acute MPH exposure (1-300 microM) caused concentration-dependent inhibition of spontaneous activity.
  • IC50 values for spike rate inhibition were approximately 110 microM for both ACNs and FCNs.
  • Sub-chronic exposure (1 mM for 24 h) blocked activity, with partial recovery after 15 hours.

Conclusions:

  • Methylphenidate exhibits concentration-dependent functional neurotoxicity.
  • Electrophysiological impairment is observed, with potential for partial reversibility after sub-chronic exposure.
  • Findings highlight the importance of dose-dependent effects in MPH neurotoxicity relevant to ADHD treatment.

More Related Videos

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...